FXIa-IN-13结构式
|
常用名 | FXIa-IN-13 | 英文名 | FXIa-IN-13 |
|---|---|---|---|---|
| CAS号 | 2629361-99-3 | 分子量 | 545.97 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C29H24ClN3O6 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
FXIa-IN-13用途FXIa-IN-13(实施例1)是具有抗血栓活性的因子Xa抑制剂。FXIa-IN-13在体内和体外抑制动静脉血栓形成[1]。 |
| 英文名 | FXIa-IN-13 |
|---|
| 分子式 | C29H24ClN3O6 |
|---|---|
| 分子量 | 545.97 |
|
实验名称:Oral bioavailability in Beagle dog measured upto 24 hrs by LC/MS analysis
来源:ChEMBL
靶标:N/A
External Id:CHEMBL5340570
|
|
实验名称:Selectivity index, ratio IC50 for FXIa (unknown origin) to IC50 for PKal (unknown ori...
来源:ChEMBL
靶标:N/A
External Id:CHEMBL5340553
|
|
实验名称:Half life in IG dosed Beagle dog measured upto 24 hrs by LC/MS analysis
来源:ChEMBL
靶标:N/A
External Id:CHEMBL5340569
|